13.60
2.72%
+0.36
After Hours:
13.64
0.04
+0.29%
Orthofix Medical Inc stock is currently priced at $13.60, with a 24-hour trading volume of 759.15K.
It has seen a +2.72% increased in the last 24 hours and a -1.88% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $13.16 pivot point. If it approaches the $13.57 resistance level, significant changes may occur.
Previous Close:
$13.24
Open:
$13.52
24h Volume:
759.15K
Market Cap:
$508.73M
Revenue:
$746.64M
Net Income/Loss:
$-151.40M
P/E Ratio:
-3.7158
EPS:
-3.66
Net Cash Flow:
$-107.80M
1W Performance:
+4.70%
1M Performance:
-1.88%
6M Performance:
+10.75%
1Y Performance:
-26.37%
Orthofix Medical Inc Stock (OFIX) Company Profile
Name
Orthofix Medical Inc
Sector
Industry
Phone
214-937-2000
Address
3451 Plano Parkway, Lewisville, TX
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-12-23 | Downgrade | BTIG Research | Buy → Neutral |
Sep-12-23 | Downgrade | Stifel | Buy → Hold |
Jul-19-23 | Resumed | BTIG Research | Buy |
Mar-04-22 | Upgrade | Stifel | Hold → Buy |
Oct-20-20 | Initiated | Stifel | Hold |
Oct-29-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
Jun-21-17 | Initiated | BTIG Research | Buy |
Jun-14-17 | Initiated | Ladenburg Thalmann | Buy |
May-23-17 | Initiated | SunTrust | Buy |
Jul-10-15 | Initiated | Sidoti | Buy |
May-09-13 | Downgrade | Mizuho | Buy → Neutral |
Jan-08-13 | Reiterated | Mizuho | Buy |
Jun-21-10 | Initiated | Boenning & Scattergood | Outperform |
Mar-09-10 | Reiterated | Jefferies & Co | Buy |
Feb-18-10 | Upgrade | Susquehanna Financial | Neutral → Positive |
Jan-22-10 | Initiated | Jefferies & Co | Buy |
Nov-03-09 | Upgrade | Wells Fargo | Underperform → Market Perform |
Jul-31-09 | Reiterated | Jefferies & Co | Buy |
Jul-31-09 | Upgrade | Thomas Weisel | Market Weight → Overweight |
May-26-09 | Reiterated | Jefferies & Co | Buy |
Apr-17-09 | Downgrade | Wachovia | Mkt Perform → Underperform |
Feb-19-09 | Initiated | Canaccord Adams | Buy |
Jul-07-08 | Downgrade | Wachovia | Outperform → Mkt Perform |
View All
Orthofix Medical Inc Stock (OFIX) Latest News
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
Zacks Investment Research
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
Zacks Investment Research
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up
Zacks Investment Research
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Benzinga
Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures
Zacks Investment Research
Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade
Zacks Investment Research
Orthofix Medical Inc Stock (OFIX) Financials Data
Orthofix Medical Inc (OFIX) Revenue 2024
OFIX reported a revenue (TTM) of $746.64 million for the quarter ending December 31, 2023, a +62.06% rise year-over-year.
Orthofix Medical Inc (OFIX) Net Income 2024
OFIX net income (TTM) was -$151.40 million for the quarter ending December 31, 2023, a -666.60% decrease year-over-year.
Orthofix Medical Inc (OFIX) Cash Flow 2024
OFIX recorded a free cash flow (TTM) of -$107.80 million for the quarter ending December 31, 2023, a -210.69% decrease year-over-year.
Orthofix Medical Inc (OFIX) Earnings per Share 2024
OFIX earnings per share (TTM) was -$4.14 for the quarter ending December 31, 2023, a -322.45% decline year-over-year.
About Orthofix Medical Inc
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Cap:
|
Volume (24h):